1 not yet recruiting, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Not yet recruiting 1, Terminated 1 |
Follow Overactive Bladder (OAB): new trials by email Literature Review of Overactive Bladder (OAB) trials Research Report on Overactive Bladder (OAB)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Non-invasive Saphenous Nerve Stimulation Therapy for Overactive Bladder Wearable neurostimulation system for saphenous nerve stimulation, tolterodine tartrate 4 mg extended release - Overactive Bladder (OAB) | Phase 3 | Not yet recruiting | NinaMED Pty Ltd | 290 | 2026-09-10 | 2026-08-24 |
| A Study to Evaluate Mirabegron in Pediatric Participants From 5 to Less Than 18 Years of Age With Overactive Bladder (OAB) Mirabegron, Placebo - Overactive Bladder (OAB), Pharmacokinetics of Mirabegron | Phase 3 | Terminated | Astellas Pharma Global Development, Inc. | 26 | 2021-03-15 | 2024-11-14 |
Urinary Bladder, Overactive (2)
Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Lower Urinary Tract Symptoms (2) · Male Urogenital Diseases (2) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urinary Bladder Diseases (2) · Urogenital Diseases (2) · Urologic Diseases (2) · Urological Manifestations (2)
Tolterodine Tartrate (1) · mirabegron (1)
Astellas Pharma Global Development, Inc. (1) · NinaMED Pty Ltd (1)
Australia (1) · Belgium (1) · France (1) · Malaysia (1) · Norway (1) · Philippines (1) · Russia (1) · South Korea (1) · Turkey (Türkiye) (1) · Ukraine (1) · United Kingdom (1) · United States (1)
2016 (1)